Skip to content

Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients

Institute of Emergency and Critical Care Medicine , School of Yang-Ming University

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01588886
Enrollment
9000
Registered
2012-05-01
Start date
2012-03-31
Completion date
2015-08-31
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Pneumonia

Keywords

Proton pump inhibitors, Pneumonia, Retrospective cohort study

Brief summary

Chronic kidney disease is a severe medical problem in Taiwan public health issue, which the highest incidence and prevalence rate in the world.Proton pump inhibitors may increase the risk of pneumonia appearance, which were caused by profound irreversible gastric acid suppression. The study purpose was to characterize difference of developing pneumonia in chronic kidney disease of prior use proton pump inhibitors.

Detailed description

The study used data from Taiwan Health Insurance Research Database; the investigators conducted a population-based cohort study in Taiwan. Case consisted of all patients who had a first diagnosis of chronic kidney disease for the period between 1997 and 2008. The investigators utilized the use of Proton pump inhibitor from chronic kidney disease patients.

Interventions

None listed

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Chronic kidney disease

Exclusion criteria

* excluded those patients who had ever been diagnosed with CKD before 1997

Design outcomes

Primary

MeasureTime frame
Chronic kidney disease ICD-92012-Dec

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026